Is gene therapy the next big step in vision loss treatment?

Health & Lifestyle
232

Listen to article (english)

Translate to Spanish or other 102 languages!

An increasing number of clinical trials are exploring the ways in which gene therapy could treat different forms of vision loss. Image for illustration purposes
An increasing number of clinical trials are exploring the ways in which gene therapy could treat different forms of vision loss. Image for illustration purposes

Medical News Today

- Advertisement -

An increasing number of clinical trials are exploring the ways in which gene therapy could treat different forms of vision loss. Image credit: Liliya Rodnikova/Stocksy.

Gene therapy uses genetic material, either DNA or RNA, to treat or prevent the progression of a disease. It often involves the introduction of genetic material into a person’s cells to replace a defective or missing gene. 

Although early attempts at gene therapy have been effective in achieving the expression of the therapeutic gene in the target tissue, they have also been accompanied by severe adverse effects.

- Advertisement -

Follow the link below to Medical News Today to read he full story:

https://www.medicalnewstoday.com/articles/is-gene-therapy-the-next-big-step-in-vision-loss-treatment?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-10-01&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
STHS Children’s Shares Prevention Season as RSV Season Heats Up!
Next article
Volume 4 of the Mental Wellness Resource Guide Unveiled

More Articles

Texas Rural Health Gets $56M Lifeline for Prevention and Wellness Programs

Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will award $56 million in federal funding to rural hospitals advancing prevention, wellness, and nutrition programs in their communities.

Study Projects Thousands of Missed Cancer Cases Under New Medicaid Rules

A research letter from experts at the University of Chicago Medicine, published in JAMA Oncology, warns that upcoming funding cuts and changes to federal Medicaid eligibility rules could lead to dramatic reductions in cancer screening for millions of Americans, ultimately worsening patient outcomes.

Pioneering New Frontiers in Myeloma Understanding and Care

esearch from Mayo Clinic is helping refine how multiple myeloma is diagnosed and treated, with findings that support more personalized therapies and identify promising immunotherapy strategies for aggressive forms of the disease.

Texas Surpasses $3 Billion in Opioid Settlements Following Newest Agreement

Attorney General Ken Paxton announced that a $7.4 billion settlement with Purdue Pharma, Inc. (“Purdue”) and its owners, the Sackler family, has become legally effective.
- Advertisement -